Science
 
MCTMedic

Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.

Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.

Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.

Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.

Sankararaman, S., & Sferra, T. (2018). Are We Going Nuts on Coconut Oil? Current Nutrition Reports, 107-115.

Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.

Shea, J. C., Bishop, M. D., & Parker, E. M. (2003). An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology, 36-40.

Jeppesen, P. B., & Mortensen, P. B. (1998). The influence of a preserved colon on the absortion of medium chain fat in patients with small bowel resection. Gut, 478-483.

Abu Hilal, M., Layfield, D. M., & Di Fabio, F. (2013). Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed; risk factors and management options. World J. Surg., 2918-2926.

McCray, S., & Parrish, C. R. (2011). Nutritional management of Chyle leaks. Practical gastroenterology, 12-32.

Smoke, A., & DeLegge, M. H. (2008). Chyle Leaks: Consensus on management? Nutr. Clin. Prac., 529-532.

Das, A., & Shah, P. S. (2010). Octreotide for the treatment of chylothorax in neonates. Cochrane database Syst. Rev., CD006388.

Jensen, G. L., Mascioli, E. A., & Meyer, L. P. (1989). Dietary modification of chyle composition in chylothorax. Gastroenterology.

Sahoo, T., Mangla, M. K., Sethi, A., & Thukral, A. (2018). Successful treatment of congenital chylothorax with skimmed milk and long course octreotide. BMJ Case Rep., 226347.

Neumann, L., Springer, T., Nieschke, K., Kostelka, M., & Dahnert, I. (2020). ChyloBEST: Chylothorax in infants and nutrition with low-fat breats milk. Pediatr. Cardiol., 108-113.

Hermon, M., Tenner, E., Gudrun, B., Strohmaier, W., Schlager, G., & Golej, J. (2019). Chylothorax and Chylous-like diseases in children: clinical management. Front Pediatr., 258.

Lieber, C. S., Lefevre, A., & Spritz, N. (1967). Difference in hepatic metabolism of long- and medium-chain fatty acids; the role of fatty acid chain length in the production of the alcohol fatty liver. The journal of clinical investigation, 451-460.

Nanji, A. A., Yang, E. K., & Fogt, F. (1996). Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol. Exp. Ther., 1694-1700.

Ronis, M. J., Baumgardner, J. N., Sharma, N., Vantrease, J., Ferguson, M., Tong, Y., . . . Badger, T. M. (2013). Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med., 151-162.

Morgan, M. H., Bolton, C. H., Morris, J. S., & Read, A. E. (1974). Medium chain triglycerides and hepatic encephalopathy. Gut, 180-184.

Chamma, C. M., Bargut, T. C., Mandarim-de-Lacerda, C. A., & Aguila, M. B. (2017). A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct., 778-787.

Williams, T. J., & Cervenka, M. C. (2017). The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin. Neurophysiol. Pract., 154-160.

van Berkel, A. A., IJff, D. M., & Verkuyl, J. M. (2018). Cognitive benefits of the ketogenic diet in patients with epilepsy, a systematic overview. Epilepsy Behav., 69-77.

Sadeghifar, F., & Baute Penry, V. (2019). Mechanisms of uses of dietary therapy as a treatment for epilepsy: a review. Global advances in health and medicine, 1-4.

Liu, Y. C., & Wang, H. S. (2013). Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed. J. , 9-15.

Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, H., . . . Williams, R. S. (2018). Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol., 84-93.

Cameros-Luna, L., & Massieu, L. (2020). Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochem. Int., 104614.

Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton-liger, F., & Paquet, C. (2020). Are ketogenic diets promising for Alzheimer's disease? a translational review. Alzheimer's Research & Therapy, 10.1186/s13195.

Abuduxikuer, K., Chen, R., Wang, Z. L., & Wang, J. S. (2019). Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin defiency (NICCD) and clinical implications. BMC Pediatr., 10.1186/s12887-018-1383-5.

Francavilla, R., Miniello, V. L., Brunetti, L., Lionette, M. E., & Armenio, L. (2003). Hepatitis and cholestasis in infancy: clinical and nutritional aspects. Acta Paediatr. Suppl., 10.1111/j.1651-2227.2003.tb00656.x.

Hayasaka, K., & Numakura, C. (2018). Adult-onset type II citrullinemia; Current insights and therapy. Appl. Clin. Genet., 163-170.

Biewer, E. S., Zurn, C., Arnold, R., Glockler, M., Schulte-Monting, J., Schlensak, C., & Dittrich, S. (2010). Chylothorax after surgery on congenital heart disease in newborns and infants - risk factors and efficacy of MCT diet. J. Cardiothorac. Surg., 10.1186/1749-8090-5-127.

Korff, S. G., Ross, J., Morella, K., & Taylor, S. N. (2019). Investigation of a common clinical approach to poor growth in preterm infants. Am. J. Perinatol., 10.1055/s-0039-1694724.

Arsenault, A. B., Gunsalus, K. T., Laforce-Nesbitt, S. S., Przytac, L., DeAngelis, E. J., Hurley, M. E., . . . Bliss, J. M. (2019). Dietary supplementation with medium-chain triglycerides reduces candida gastrointestinal colonization in preterm infants. Pediatr. Infect. Dis. J., 164-168.

 
ProtiMedic

Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.

Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.

Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.

Carbone, J. W., & Pasiakos, S. M. (2019). Dietary protein and muscle mass: translating science to application. Nutrients, 1136.

Carbone, J. W., McClung, J. P., & Pasiakos, S. M. (2019). Recent advances in the characterization of skeletal muscle and whole-body protein responses to dietary protein and exercise during negative energy balance. Adv. Nutri., 70-79.

Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.

Loenneke, J. P., Loprinzi, P. D., Murphy, C. H., & Phillips, S. M. (2016). Per meal dose and frequency of protein consumption is associated with lean mass and muscle performance. Clin. Nutr., 1506-1511.

Berner, L. A., Becker, G., Wise, M., & Doi, J. (2013). Characterization of dietary protein among older adults in the United States: Amount, animal sources, and meal patterns. J. Acad. Nutr. Diet., 809-815.

Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.

Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.

MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/

Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.

Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.

Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.

Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.

Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.

Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.

Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.

Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.

Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.

Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.

Bozzetti, F. (2013). Nutritional support of the oncology patient. Crit. Rev. Oncol. Hematol., 172-200.

Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.

Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.

Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.

Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Heart Failure Reviews, 10.1007/s10741-020-09937-9.

Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.

Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.

Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.

Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.

 
GlutaMedic

Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.

Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.

Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.

Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.

Durani, S. (2008). Protein design with L- and D-alpha-amino acid structures as the alphabet. Acc. Chem. Res., 1301-1308.

Amino acids. (2020). Retrieved from MedlinePlus: https://medlineplus.gov/ency/article/002222.htm

Kim, H. (2011). Glutamine as an immononutrient. Yonsei Med. J., 892-897.

Lenders, C. M., Liu, S., Wilmore, D. W., Sampson, L., Dougherty, L. W., Spiegelman, D., & Willett, W. C. (2009). Evaluation of a novel food composition database that includes glutamine and other amino acids derived from gene squencing data. Eur. J. Clin. Nutr., 1433-1439.

Gleeson, M. (2008). Dosing and efficacy of glutamine supplementation in human exercise and sport training. The Journal of Nutrition, 2045S-2049S.

Demling, R. H. (2009). Nutrition, anabolism, and the wound healing process: an overview. Eplasty, e9.

Mittendorfer, B., Gore, D. C., Herndon, D. N., & Wolfe, R. R. (1999). Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. J. Parenter. Enteral Nutr., 243-250.

Calder, P. C., & Yaqoob, P. (1999). Glutamine and the immune system. Amino acids, 227-241.

Hulst van der, R. R., Meyenfeldt von, M. F., & Soeters, P. B. (1996). Glutamine: an essential amino acid for the gut. Nutrition, S78-S81.

Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P., Casaer, M. P., . . . Pichard, C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition, 48-79.

Rodas, P. C., Rooyackers, O., Hebert, C., Norberg, A., & Wernerman, J. (2012). Glutamine and glutathione at ICU admission in relation to outcome. Clin. Sci., 591-597.

Zanten van, A. R., Dhaliwal, R., Garrel, D., & Heyland, D. K. (2015). Enteral glutamine supplementation in critically ill patients; a systematic review and meta-analysis. Crit. Care, 19:294.

Rousseau, A., Losser, M. R., Ichai, C., & Berger, M. M. (2013). ESPEN endorsed recommendations: nutritional therapy in major burns. Clin. Nutr., 497-502.

Houdijk, A. P., Rijnsburger, E. R., Wesdorp, R. I., Weiss, J. K., McCamish, M. A., & Teerlink, T. (1998). Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet, 772-776.

Wischmeyer, P. E. (2019). The glutamine debate in surgery and critical care. Curr. Opin. Crit. Care, 322-328.

Chen, M. J., Wu, I. C., Chen, Y. J., Wang, T. E., Chang, Y. F., Yang, C. L., . . . Wu, M. S. (2018). Nutrition therapy in esophageal cancer-consensus statement of the gastroenterological society of Taiwan. Dis. Esophagus., 10.1093/dote/doy016.

Jolfaie, N. R., Mirzaie, S., Ghiasvand, R., Askari, G., & Miraghajani, M. (2015). The effect of glutamine intake on complications of colorectal and clon cancer treatment: a systematic review. J. Res. Med. Sci., 910-918.

 
S-Core

Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.

Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.

Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.

MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/

Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.

Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.

Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.

Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.

Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.

Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.

Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.

Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.

Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.

Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.

Bozzetti, F. (2013). Nutritional support of the oncology patient. Crit. Rev. Oncol. Hematol., 172-200.

Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.

Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.

Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.

Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Heart Failure Reviews, 10.1007/s10741-020-09937-9.

Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.

Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.

Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.

Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.

Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.

Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.

Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.

Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.

Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.

Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.

Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.

Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.

Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.

Mikkelsen, K., & Apostolopoulos, V. (2018). B Vitamins and ageing. Subcell Biochem., 451-470.

Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., . . . Singer, P. (2017). ESPEN guideline: clinical nutrition in surgery. Clinical Nutrition, 623-650.

Gillis, C., & Carli, F. (2015). Promoting perioperative metabolic and nutritional care. Anesthesiology, 1455-1472.

Williams, D. G., Molinger, J., & Wischmeyer, P. E. (2019). The malnourished surgery patient: a silent epidemic in perioperative outcomes? Curr. Opin. Anaesthesiol., 405-411.

Bisschoff, S. C., Austin, P., Boeykens, K., Chourdakis, M., Cuerda, C., Jonkers-Schuitema, C., . . . Pironi, L. (2020). ESPEN guideline on home enteral nutrition. Clinical Nutrition, 5-22.

 
C-Core

WHO. (2018). Cancer. Retrieved from https://www.who.int/en/news-room/fact-sheets/detail/cancer

Rauh, S., Antonuzzo, A., Bossi, P., Eckert, R., Fallon, M., Frobe, A., . . . Villarini, A. (2018). Nutritionin patients with cancer: a new are for medical oncologists? A practising oncologist's interdisciplinary position paper. ESMO open, Doi:10.1136/esmoopen-2018-000345.

Pressoir, M., Desne, S., Berchery, D., Rossignol, G., Poirree, B., & Meslier, M. (2010). Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive cancer Centres. Br. J. Cancer, 966-971.

Wie, G. A., Cho, Y. A., Kim, S. Y., Kim, S. M., Bae, J. M., & Joung, H. (2010). Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the national cancer center in Korea. Nutrition, 263-268.

Hebuterne, X., Lemarie, E., Michallet, M., Montreuil de, C. B., Schneider, S. M., & Goldwasser, F. (2014). Prevalence of malnutrition and current use in nutrition support in patients with cancer. J. Parenter. Enteral Nutr., 196-204.

Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., . . . Lisanti, M. P. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.

Freijer, K., Tan, S. S., Koopmanschap, M. A., Meijers, J. M., Halfens, R. J., & Nuijten, M. J. (2013). The economic costs of disease related malnutrition. Clinical Nutrition, 136-141.

Barr, R. D., & Ladas, E. J. (2020). The role of nutrition in pediatric oncology. Expert Review of Anticancer Therapy, 10.1080/14737140.2020.1719834.

Laird, B. J., Fallon, M., Hjermstad, M. J., Tuck, S., Kaasa, S., & Klepstad, P. (2016). Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response. J. Clin. Oncol., 2769-2775.

Fearon, K., Arends, J., & Baracos, V. (2013). Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol., 90-99.

Argiles, J. M., Busquets, S., Stemmler, B., & Lopez-Soriano, F. J. (2014). Cancer cachexia: understanding the molecular basis. Nat. Rev. Cancer, 754-762.

Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C. (2014). The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid. Redox Signal., 1516-1554.

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., & Bozzetti, F. (2017). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 11-48.

Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., & Fainsinger, R. L. (2011). Definition and classification of cancer cachexia: an international consensus. Lancet Oncol., 489-495.

Stanga, Z., Brunner, A., Leuenberger, M., Grimble, R. F., Shenkin, A., & Allison, A. P. (2008). Nutrition in clinical practice- the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur. J. Clin. Nutr., 687-694.

Lee, J. L., Leong, L. P., & Sim, S. L. (2016). Nutrition intervention approaches to reduce malnutrition in oncology patients: a systematic review. Support Care Cancer, 469-480.

Prado, C. M., Mourtzakis, M., Baracos, V., Reiman, T., Sawyer, M., & McCargar, L. J. (2010). Overweight and obese patients with solid tumors may have sarcopenia, poor prognosis and early features of cachexia. Int. J. Body Compos. Res., 7-15.

Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of Cachexia, Sarcopenia and Muscle, 366-380.

Ravasco, P. (2019). Nutrition in Cancer Patients. Journal of Clinical Medicine, 10.3390/jcm8081211.

Grober, U., Holzhauer, P., Kisters, K., Holick, M. F., & Adamietz, I. A. (2016). Micronutrients in oncology intervention. Nutrients, 10.3390/nu8030163.

Jatoi, A., Williams, B. A., Marks, R., Nichols, F. C., Aubry, M., Wampfler, J., & Yang, P. (2005). Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the mayo clinic lung cancer cohort. Nutr. Cancer, 77-84.

  • LinkedIn
  • Twitter
  • Instagram

This Website may contain general information relating to various medical conditions and their treatment.  Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified health care professional.  Patients should not use the information contained herein for diagnosing a health problem or disease.  Patients should always consult with a doctor or other health care professional for medical advice or information about diagnosis and treatment.

Copyright © 2020 Dutch Medical Food BV. All rights reserved.